# Orthoptics in the United States

## Executive synthesis

The strongest public evidence suggests that **U.S. orthoptics is a very small, capacity-constrained allied-health profession that sits in high-value bottlenecks inside ophthalmology**, especially pediatric ophthalmology, adult strabismus, and neuro-ophthalmology. The public-facing U.S. literature does **not** provide a clean, current census of actively practicing orthoptists. The best publicly visible U.S. proxy I found is that **all 440 registered members of the American Association of Certified Orthoptists were surveyed in early 2022**, which implies a profession numbered in the **low hundreds, not thousands**. AOC materials simultaneously indicate **17** accredited U.S. programs on one page and a live list naming **18** programs on another, underscoring how thin and inconsistent the public data infrastructure is. Publicly posted program capacity suggests a pipeline that is probably only in the **teens of graduates per year**, not the dozens or hundreds. citeturn13search8turn15search1turn3view0turn10search0turn10search1turn10search2

The profession’s value proposition is clearer than its headcount. Orthoptists are specialized measurers, diagnosticians, and non-surgical managers of **strabismus, amblyopia, diplopia, convergence/accommodative dysfunction, nystagmus, and selected neuro-ophthalmic disorders**, and they are explicitly framed by AOC/AAPOS as **physician extenders** who can run follow-up templates, perform billable sensorimotor services, and free ophthalmologist time. The best quantified U.S. efficiency claim is an older AAPOS manpower-survey figure cited by AACO: adding one full-time orthoptist was associated with **up to 50% higher patient volume** and **28% higher surgical volume**. That statistic is useful, but because the underlying survey is old and not easily auditable from the public web, it should be treated as **low-confidence** rather than definitive. citeturn15search0turn20view0turn21view0

The most rigorous outcome evidence on access, safety, and efficiency comes mainly from **UK/Australian orthoptist-led service models**, which are appropriate as benchmarks but not substitutes for U.S.-specific proof. In these studies, orthoptists matched ophthalmologists closely on management decisions in glaucoma and neuro-ophthalmology pathways, delivered very high patient satisfaction, and reduced visit time and cost in structured screening clinics. Meanwhile, U.S. pediatric-ophthalmology geography suggests the care environment orthoptists support is itself thinly distributed: a 2023 JAMA Ophthalmology study found **1,056 pediatric ophthalmologists in the United States**, only **12.7 per 1 million people younger than 19 years**, and **90% of counties had no pediatric ophthalmologist**. Because orthoptists usually work alongside those subspecialists, this is the best available U.S. proxy for likely orthoptic maldistribution. citeturn28view0turn29view0turn30view0turn47search2turn47search7

## Stat cards

| Value | Metric / what it measures | Scope & population | Period | Source (+URL) | Confidence | One-line “so what” |
|---|---|---|---|---|---|---|
| **440 registered members** | Best public proxy for the size of the U.S. certified-orthoptist community; survey denominator was “all 440 registered members of the AACO” | U.S. AACO membership, not a verified census of active practitioners | Early 2022 survey fielding; article published 2023 | *A Survey to Identify Screen Test Usage by Certified Orthoptists Across the United States of America* snippet and abstract references. citeturn13search8turn13search2 | **[Estimate]** | The public evidence points to a profession in the **low hundreds** in the U.S., but not an exact active-workforce count. |
| **No public current AOC census found** | Absence of a publicly posted national count of currently practicing certified orthoptists | U.S. certified orthoptists | As accessed 2026 | AOC employer-information page directs employers to contact the home office for individual verification, not a public directory. citeturn14view0 | **[Measured]** | The biggest basic workforce question—“how many are practicing now?”—is not publicly answered by the certifying body. |
| **17 accredited U.S. programs** | Count stated on AOC “Become an Orthoptist” page | United States | Page current as accessed 2026 | AOC “Become an Orthoptist.” citeturn15search1 | **[Measured]** | One official AOC page says 17 programs. |
| **18 named U.S. programs** | Count from the live AOC/AACO program listing | United States | Page current as accessed 2026 | AOC/AACO live program list naming Bascom Palmer, Duke, Iowa, CHOP, Wisconsin, etc. citeturn3view0turn40search14 | **[Measured]** | Another official page lists **18** programs, so public program counts conflict and should be reported transparently. |
| **24 months** | Standard orthoptic training length | AOC-accredited U.S. programs | Current standards, approved 2023 | AOC Scope of Practice and AOC “Become an Orthoptist.” citeturn15search0turn15search1 | **[Measured]** | Orthoptic training is longer and more formalized than technician training, which is central to the profession’s value claim. |
| **≥2,000 supervised clinical hours and ≥1,250 patient encounters** | Minimum clinical training exposure in AOC programs | U.S. orthoptic trainees | Current standards, approved 2023 | AOC Scope of Practice. citeturn15search0 | **[Measured]** | Orthoptists are trained through high-volume, hands-on clinical exposure before certification. |
| **1 student per year** | Published annual intake | University of Minnesota orthoptic program | Current webpage, accessed 2026 | University of Minnesota Orthoptic Program. citeturn10search0 | **[Measured]** | At least some U.S. programs train only **one** orthoptist per year. |
| **1 student per year** | Published annual intake | Bascom Palmer Eye Institute orthoptic fellowship | Current webpage, accessed 2026 | Bascom Palmer Orthoptic Fellowship. citeturn10search2 | **[Measured]** | Another major program also trains only **one** student per year. |
| **1 student every 2 years** | Published intake frequency | University of Wisconsin orthoptist training program | Current webpage / 2025 report | University of Wisconsin program page and 2025 department report. citeturn10search1turn10search5turn10search11 | **[Measured]** | Some programs produce less than one graduate per year, further constraining the U.S. pipeline. |
| **Likely only teens of graduates per year nationally** | Inferred graduation/output capacity from publicly visible program counts and published intakes | United States | 2025–2026 public program information | Synthesized from AOC program counts and published intake examples above. citeturn15search1turn3view0turn10search0turn10search1turn10search2 | **[Estimate]** | Even if most programs fill one slot annually, the U.S. pipeline appears too small to rapidly expand the workforce. |
| **100% placement; employment opportunities exceed available orthoptists** | Program-reported job-market outcome | University of Iowa graduates / U.S. market | Current webpage, accessed 2026 | University of Iowa Orthoptic Training program. citeturn9search4turn40search2 | **[Measured]** | The market signal from a major program is shortage, not oversupply. |
| **13 active job postings** | Open orthoptist vacancies listed on the AACO job board | U.S. employers | Jan 15–Jun 17, 2026 snapshot | AACO employment opportunities page. citeturn41view0 | **[Measured]** | A small profession had at least 13 visible openings in 6 months, supporting ongoing demand. |
| **51% public, 36% private, 13% mixed** | Practice-setting mix among respondents | 135 certified-orthoptist survey respondents in the U.S. | Early 2022 survey; article 2023 | *Screen Test Usage by Certified Orthoptists* snippet. citeturn13search8 | **[Measured]** | U.S. orthoptists are split between hospitals/academic or public settings and private ophthalmology practices. |
| **Common duties include 92060, 92065, 92015, 99211, Q3014** | Billable exam/training/visit codes explicitly named by AOC for orthoptist practice patterns | U.S. orthoptist clinics | AOC scope approved Feb 2023 | AOC Scope of Practice. citeturn15search0 | **[Measured]** | Orthoptists are not just “helpers”; they occupy reimbursable clinical workflow in ophthalmology. |
| **General supervision required for 92060 and 92065** | Medicare supervision level for sensorimotor exam and orthoptic training | U.S. orthoptist services under ophthalmologist oversight | AAPOS policy reaffirmed 2017; still cited publicly | AAPOS policy statement, *Orthoptists as Physician Extenders*. citeturn20view0 | **[Measured]** | These services can be delegated without the physician physically present, which is exactly how extender models create capacity. |
| **Up to 50% higher patient volume; average 28% higher surgical volume** | Practice-level productivity gain associated with adding one full-time orthoptist | AAPOS member manpower survey, practice-level claim | 2007 survey, cited by AACO in 2026 | AACO “Orthoptists are Physician Extenders.” citeturn21view0 | **[Low-confidence]** | This is the clearest U.S. productivity number, but it is old and the underlying survey is not readily auditable online. |
| **41,300 employment; 2% growth; median wage $113,730** | BLS parent-group outlook for “Healthcare Diagnosing or Treating Practitioners, All Other,” the SOC group containing Orthoptists | United States, parent occupation group | 2024 employment and 2024–2034 projections | BLS Occupational Outlook Handbook “occupations not covered in detail.” citeturn16view0 | **[Low-confidence]** | BLS does **not** publish orthoptist-specific employment or growth; only the parent “all other” group is available. |
| **Below-average outlook; salary $115,210** | O*NET/My Next Move profile for Orthoptists | United States | Site updated May 19, 2026 | My Next Move / O*NET Orthoptists profile. citeturn17view0 | **[Low-confidence]** | O*NET provides a job-outlook signal, but because orthoptists are extremely small in number, the estimate should be treated cautiously. |
| **1,056 pediatric ophthalmologists** | Number of pediatric ophthalmologists identified in public databases | United States | March 2022 provider identification, article 2023 | Walsh et al., *Access to Pediatric Ophthalmological Care by Geographic Distribution in the United States*. citeturn47search2turn47search7 | **[Measured]** | This is an ophthalmology proxy for where orthoptists are most likely to cluster, because orthoptists usually co-practice with these subspecialists. |
| **12.7 pediatric ophthalmologists per 1 million people younger than 19 years** | Pediatric-ophthalmology supply ratio | United States, population younger than 19 years | March 2022 provider identification, article 2023 | Same JAMA Ophthalmology study and summaries. citeturn47search2turn47search13 | **[Measured]** | Even the physician workforce orthoptists support is thin nationally. |
| **90% of U.S. counties lacked a pediatric ophthalmologist** | Geographic maldistribution proxy for orthoptic access | United States counties | March 2022 provider identification, article 2023 | Same JAMA Ophthalmology study summary. citeturn47search2turn47search7 | **[Measured]** | The orthoptic workforce is very likely to share this maldistribution because most orthoptists are embedded in tertiary pediatric or strabismus practices. |
| **163 patients; 100% agreement on visual function status and OCT interpretation; 100% satisfied; 96% willing to return** | Safety and satisfaction of an orthoptist-led virtual neuro-ophthalmology clinic | Manchester Royal Eye Hospital virtual clinic patients | Jan–Aug 2021 audit; article 2023 | Smith et al., *A Quality Assurance Audit of an Orthoptic-Led Virtual Neuro-Ophthalmology Clinic*. citeturn28view0 | **[Measured]** | In a structured pathway, orthoptists can safely monitor selected neuro-ophthalmology patients and preserve ophthalmologist capacity. |
| **18 of 21 encounters agreed; κ=0.690; follow-up agreement 13 of 18, κ=0.639** | Orthoptist–ophthalmologist agreement in glaucoma management | Tertiary-hospital orthoptist-led glaucoma clinic, Victoria, Australia | 11-month audit; article 2021 | Koklanis & Thorburn, *Orthoptist-Led Glaucoma Monitoring*. citeturn29view0 | **[Measured]** | This is benchmark evidence that trained orthoptists can make reliable management decisions outside classic strabismus work. |
| **25.85 vs 45.11 minutes; A$20.40 vs A$84.15; A$63.75 savings per visit** | Time and cost comparison of orthoptist-led vs consultant-led NF1 screening clinics | Pediatric NF1 screening encounters, Australia | 2014–2018 appointments; article 2023 | Kaur et al., *Cost Analysis of Orthoptist-Led Neurofibromatosis Type 1 Screening Clinics*. citeturn30view0 | **[Measured]** | Orthoptist-led clinic design can be materially faster and cheaper while preserving specialist review for abnormal cases. |
| **95% limits of agreement on one PACT measurement for deviations >20 PD: ±7.3 PD distance, ±8.3 PD near; on a difference between two measurements: ±10.4 PD distance, ±11.7 PD near** | Reliability of prism and alternate cover testing for esotropia | 143 children ≤60 months with esotropia | Study published 2009 | PEDIG, *Interobserver Reliability of the Prism and Alternate Cover Test in Children With Esotropia*. citeturn24search0turn24search3turn24search13 | **[Measured]** | Orthoptics adds value precisely because strabismus measurements have real variability and need skilled, standardized examiners. |
| **Only changes ≥10 PD are generally clinically meaningful** | Threshold for “real change” in prism-cover measurements | Strabismus measurements | Study published 2008 | Holmes et al., *Defining Real Change in Prism-Cover Test Measurements* and later papers citing it. citeturn24search2turn23search11 | **[Measured]** | This shows why repeatable orthoptic measurement matters for surgical planning and follow-up. |
| **Approximately half of strabismus reoperations attributable to measurement inaccuracy, strategy variability, and imprecise surgery** | Estimated share of reoperations due to human error factors | Strabismus surgery modeling study | Study published 2009 | Schutte et al., *Human Error in Strabismus Surgery*. citeturn23search1turn23search4turn23search10 | **[Modeled]** | Pre-operative orthoptic measurements are not clerical details; they can change whether surgery succeeds. |
| **82% had dose-relevant angle changes ≥3 pdpt after prism adaptation; 51% of decompensated microesotropia cases changed ≥10 pdpt or decreased ≥3 pdpt** | Impact of prism adaptation testing before strabismus surgery | Patients with decompensated esophoria or decompensated microesotropia | Study published 2022 | Gietzelt et al., *Prism Adaptation Test Before Strabismus Surgery*. citeturn26search1turn26search3turn26search6 | **[Measured]** | Orthoptic pre-op testing can materially change the surgical dose or even the diagnosis. |
| **419 children at 47 clinical sites** | Scale of a landmark PEDIG amblyopia RCT comparing atropine vs patching | Children <7 years with moderate amblyopia | Enrollment Apr 1999–Apr 2001; main trial 2002 | PEDIG / Arch Ophthalmol amblyopia trial. citeturn49search0turn49search6turn49search12 | **[Measured]** | Landmark pediatric-ophthalmology evidence was built in the exact disease space orthoptists co-manage every day. |
| **221 children aged 9–17 years** | Scale of the Convergence Insufficiency Treatment Trial | School-age children with symptomatic convergence insufficiency | Trial published 2008 | CITT trial materials. citeturn49search2turn49search20turn49search23 | **[Measured]** | Orthoptics is not only about strabismus surgery support; it also contributes to evidence in binocular-vision rehabilitation. |
| **1,589 orthoptists on the HCPC register** | Orthoptic workforce size on the UK regulator’s register | United Kingdom | Snapshot 7 Jan 2025 | HCPC registrant snapshot. citeturn33view0 | **[Measured]** | The UK has a far more visible and measurable orthoptic workforce than the U.S. |
| **87.9 WTE and 111 headcount; 5.4 WTE vacancies; 3.5 WTE locums/bank; 8 WTE expected to retire in 5 years** | Orthoptist workforce, vacancies, and retirement risk in Scotland’s ophthalmology departments | NHS Scotland mainland territorial Health Boards | May 2022 review, report 2023 | *National Ophthalmic Workforce Review* for Scotland. citeturn39view0 | **[Measured]** | Even in a country that measures orthoptics well, vacancies and retirement pressure are already visible. |
| **30–40% further demand expected over 20 years in ophthalmology** | Service-demand growth context for hospital eye services | NHS / ophthalmology outpatient demand | Cited in 2023 neuro-ophthalmology audit | Smith et al. neuro-ophthalmology audit introduction. citeturn28view0 | **[Modeled]** | Orthoptist role expansion is happening because ophthalmology demand is rising faster than specialist physician capacity. |

## Narrative

The U.S. orthoptic profession is **small, specialized, and undercounted**. The public record is unusually thin for such a clinically important role: AOC does not publish a public national directory of currently practicing certified orthoptists, and the best public size proxy is still the **440 AACO members** surveyed in early 2022. Even the training-program count is internally inconsistent, with one AOC page saying **17** U.S. programs and the live list naming **18**. What is clear is that the training pipeline is tiny. Published examples show programs commonly accept **one trainee per year**, and one established program reports **one trainee every two years**. Taken together, the likely steady-state U.S. output is only in the **teens of graduates per year**, which aligns with program-level claims of **100% placement** and more openings than graduates. The 2026 AACO job board snapshot—**13 listings in six months**—reinforces the same story: this is a shortage profession, but the exact U.S. shortage size is not publicly measured. citeturn13search8turn14view0turn15search1turn3view0turn10search0turn10search1turn10search2turn9search4turn41view0

Clinically, orthoptists create value where ophthalmology most needs **high-skill delegation** rather than generic staff substitution. AOC and AAPOS explicitly place orthoptists in the allied-health/physician-extender lane: they perform **sensorimotor examinations, pre- and postoperative strabismus measurements, amblyopia management, prism trials, diplopia workups, selected refractions, and follow-up care under delegated supervision**. Their work matters because measurement quality matters. PEDIG’s interobserver-reliability study showed that even standardized prism-cover testing has wide enough limits of agreement that only relatively large changes are clearly “real,” and Schutte’s sensitivity analysis estimated that **about half of strabismus reoperations** arise from a combination of measurement error, strategy variation, and surgical imprecision. Put simply: if orthoptic measurements are off, the surgical plan can be off. The 2022 prism-adaptation study makes that even more concrete, showing **dose-relevant changes in 82%** of decompensated esophoria cases and major angle shifts in **51%** of decompensated microesotropia cases before surgery. citeturn15search0turn20view0turn24search0turn24search2turn23search1turn26search1turn26search3

On access and efficiency, the direct U.S. evidence base is disappointingly thin, but the evidence that exists points in a consistent direction. The older AAPOS manpower-survey statistic—**up to 50% more patient volume and 28% more surgical volume** with one full-time orthoptist—should be treated as suggestive, not conclusive, because the underlying survey is old and not easy to audit publicly. The stronger contemporary evidence comes from structured orthoptist-led services outside the U.S.: in a virtual neuro-ophthalmology clinic, orthoptists achieved **100% agreement** with consultants on visual-function status and OCT interpretation, while **100% of patients were satisfied** and **96% would return**; in glaucoma monitoring, orthoptists achieved **85.7% management agreement** with a consultant ophthalmologist; and in NF1 optic-pathway-glioma screening, an orthoptist-led pathway cut mean clinician time from **45.11 to 25.85 minutes** and mean labor cost from **A$84.15 to A$20.40** per appointment. These are not U.S. data, but they are highly relevant because they quantify the same fundamental mechanism orthoptists offer to ophthalmology everywhere: **safe redistribution of stable, protocolized work away from the scarcest physician time**. citeturn21view0turn28view0turn29view0turn30view0

The profession’s broader value also extends into evidence generation. PEDIG’s amblyopia and binocular-vision trials enrolled **419 children at 47 sites** in the atropine-versus-patching trial and **221 children** in the CITT study of symptomatic convergence insufficiency. Public trial summaries quantify enrollment and outcomes rather than the exact labor share of orthoptists, so the research-contribution claim must be phrased carefully: **orthoptists’ clinical domain is exactly the domain in which landmark pediatric-ophthalmology trials have changed practice**, and AOC explicitly lists research participation and education among orthoptists’ scope. That is indirect but still meaningful evidence of profession-level value. citeturn15search0turn49search0turn49search6turn49search20

For U.S. geography and demographics, public orthoptics-specific data are weak. I did **not** find a recent national AOC/AACO dashboard reporting age, sex, race/ethnicity, or state distribution for the U.S. orthoptic workforce. The best U.S. geography proxy is pediatric ophthalmology: the 2023 JAMA Ophthalmology analysis found **1,056 pediatric ophthalmologists nationwide**, **12.7 per million children and adolescents**, and **90% of counties without one**. Because orthoptists disproportionately co-practice with pediatric ophthalmologists, adult-strabismus surgeons, and neuro-ophthalmologists, the most defensible interpretation is that orthoptist access is likely concentrated in the same tertiary and metropolitan hubs. That is an inference, not a direct orthoptic census finding. citeturn47search2turn47search7turn47search13

## International benchmark

The UK shows what the profession can look like when it is **formally regulated, routinely counted, and deliberately expanded**. On the HCPC regulatory register there were **1,589 orthoptists** on **7 January 2025**, which means the UK can answer basic workforce questions that the U.S. public record still cannot. Scotland’s 2023 national ophthalmic workforce review then drills down further: as of **May 2022**, NHS Scotland had **87.9 WTE orthoptists (111 headcount)** in ophthalmology departments, **5.4 WTE vacancies**, **3.5 WTE locum/bank use**, and **8 WTE expected retirements within five years**. That same report shows orthoptists are not confined to classic squint clinics; they are part of planned workforce models across ophthalmology services. citeturn33view0turn39view0

The UK benchmark is valuable less because the absolute numbers can be transplanted to the U.S., and more because it demonstrates that orthoptics can be a **measurable service-delivery lever**. In neuro-ophthalmology, orthoptist-led virtual review achieved consultant-level agreement on key monitored parameters and excellent satisfaction. In glaucoma and NF1 surveillance, orthoptist-led models showed safety, time savings, and lower labor cost. BIOS’s more recent workforce-development work also centers role expansion into hospital eye services and improved efficiency, including refractive and pathway-redesign projects, although many of those newer implementation reports are not yet backed by peer-reviewed outcome studies. Taken together, the UK benchmark suggests the U.S. profession’s ceiling is likely much higher than current public U.S. data capture would imply. citeturn28view0turn29view0turn30view0turn31search1

## Data gaps

The evidence base cannot currently answer several important questions well:

- **How many certified orthoptists are actively practicing in the U.S. right now?** Public AOC/AACO materials do not provide a current active-practice census. The **440-member AACO denominator from 2022** is the best public proxy I found, but it is not the same as an audited workforce count. citeturn13search8turn14view0
- **How many orthoptists graduate per year nationally?** Program count is public, but annual seat counts are not consistently published. Only some programs disclose intake, and at least one accepts a trainee only every other year. citeturn10search0turn10search1turn10search2turn15search1
- **What are the U.S. orthoptic workforce demographics?** I did not find a recent public national dataset for U.S. orthoptist age, sex, race/ethnicity, or state-by-state distribution.
- **What is the U.S. supply-demand gap in hard numbers?** There are strong shortage signals—program-reported 100% placement, visible job ads, and tiny training capacity—but no public U.S. model estimating vacancies, unmet demand, or needed workforce expansion. citeturn9search4turn41view0
- **How much ophthalmologist capacity does an orthoptist create in modern U.S. practice?** The best public number is the older AAPOS manpower-survey claim of **up to 50% more patient volume and 28% more surgical volume**, but contemporary U.S. throughput and wait-time studies are missing. citeturn21view0
- **What is the U.S.-specific economic case?** The best cost-effectiveness studies I found were from Australia/UK service models, not U.S. health systems. citeturn29view0turn30view0
- **How much of PEDIG and related research execution is done by orthoptists?** The landmark trials clearly inhabit the orthoptic clinical domain, but public trial summaries do not quantify orthoptists’ direct operational contribution site by site. citeturn49search6turn49search20

## Bottom line

The defensible quantitative conclusion is that **orthoptics in the United States is a small, specialized, and probably undersupplied profession whose measurable value lies in being a high-skill ophthalmology extender for binocular-vision, eye-movement, amblyopia, strabismus, and neuro-ophthalmic care**. The public U.S. workforce data are too weak to provide a clean national headcount, demographic profile, or vacancy model. But the combination of **tiny training capacity, persistent job postings, program-reported full placement, and strong international shared-care evidence** points in one direction: when orthoptists are available, they can **expand ophthalmologist capacity, protect measurement quality in strabismus care, and lower the cost or time burden of selected pathways**. The profession’s main U.S. problem is not lack of apparent value. It is **lack of transparent measurement and scale**. citeturn13search8turn15search1turn41view0turn28view0turn29view0turn30view0